Ingrid Holm, MD, MPH

Ethical, legal, and social implications (ELSI) of genomics, and rare disease research

Dr. Holm obtained her MD at the University of California, Los Angeles and completed her pediatric residency and dual fellowship in Medical Genetics and Pediatric Endocrinology at Boston Children’s Hospital. She completed the Harvard Pediatric Health Services Research Fellowship, received her Masters of Public Health (MPH) at the Harvard T.H. Chan School of Public Health. She received a certificate in Pediatric Bioethics from Children’s Mercy Center for Bioethics. She is a faculty member of the Center for Bioethics at Harvard Medical School. Dr. Holm studies the ethical, legal, and social implications (ELSI) of genomics and her areas of interest are in the intersection of genomics, ethics, and pediatrics. She leads studies on the integration of genomic sequencing care into newborn screening in the BabySeq projects, return of results from genomic screening in the Electronic Medical Records and Genomics (eMERGE) Network, and ethical issues in n-of-1 therapies. Dr. Holm’s other area of research is in rare diseases. She is Associate Director of Robert’s Program in Sudden and Unexpected Pediatric Death (SUDP) to identify genetic contributions to SUDP, and she is a member of the Undiagnosed Disease Network (UDN) Harvard clinical site.

Dr. Holm is an Attending Physician in the Division of Genetics and Genomics and the Division of Endocrinology. She sees patients in the clinic at the Boston Children’s Hospital and is a member of the Bone Health Program and the Behavioral Health, Endocrinology, Gynecology, Urology (BEING-U) Program.

< BACK TO DIRECTORY